Paper Details

Paper Title

Targeted Therapeutics for Transthyretin Amyloid Cardiomyopathy.

Paper Journal Title

Am J Ther

Paper Citation Count

Paper Publication Year

2023

Bio Mention

ATTR-CM, TTR, TTR amyloid cardiomyopathy, Transthyretin, Transthyretin Amyloid Cardiomyopathy, amyloid, cardiac amyloidosis, diflunisal, mutant transthyretin, patients, patisiran, revusiran, tafamidis, transthyretin, transthyretin protein, transthyretin tetramers, wild-type

Mesh Descriptor

Author Name	Affiliation
Salem Almaani	the Ohio State University Wexner Medical Center
Samir M Parikh	the Ohio State University Wexner Medical Center
Samir M Parikh	the Ohio State University Wexner Medical Center

1 - 3

Dataset	Description	Source Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link
PubMed	Citations and abstracts of biomedical literature	Link

1 - 15

Paper Details

Column Actions

Datasets